Plain-English translation of NCT06053086 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a personalized approach to radiation therapy can reduce painful side effects like scarring and skin changes in breast cancer patients. Researchers first perform a quick blood test to measure how sensitive your body is to radiation, then use that information to customize your radiation treatment plan. The goal is to give you the right dose for your body — not too much, not too little.
Radiation therapy is an effective breast cancer treatment, but it can cause serious side effects like scarring and skin damage that affect quality of life. Currently, all patients receive the same radiation dose regardless of how sensitive their individual bodies are to radiation. This trial exists to see if personalizing treatment based on your body's sensitivity can reduce these unwanted side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will first have a blood test done to measure how sensitive your body is to radiation. Based on those results, you will be assigned to receive either personalized adaptive radiation therapy or standard radiation therapy. You will then receive your assigned radiation treatment and return for regular follow-up visits over time so doctors can monitor you for side effects and track how well the treatment worked.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
France